Intellectual Property Law and Copyright Laws

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

This article provides an update on developments in the biosimilar space in Canada—regulatory, approvals, pending submissions, litigation, and market access—since our March 2024 update.

The United States is a major player in development of artificial intelligence (AI) globally and has a significant impact on national (and global) conversations on the regulation of AI.

In the recent decision of Zacon Limited v Provincial Doors Inc et al, 2025 ONSC 2954 (the "Court's Decision"), the Ontario Superior Court of Justice (the "ONSC") found that, under the Patent...

The United States is a major player in development of artificial intelligence (AI) globally and has a significant impact on national (and global) conversations on the regulation of AI.

Business owners weary from endless scam and spam emails might just hit the delete button – but there is reason to be more cautious.

On June 19, 2025, I had the pleasure of presenting my annual "Computer and IT Law: The Year in Review" to the Toronto Computer Lawyers Group.

On 21 May 2025, the European Parliament and Council reached a provisional agreement on a new Regulation which establishes an EU-level framework...

专利开放许可制度作为普通专利实施许可的特殊形式，是我国专利制度体系的重要补充。

The European Medicines Agency (EMA) has published a draft Reflection Paper proposing a streamlined pathway for the approval for certain biosimilar medicinal products (biosimilars) in the EU...